Building a FAIR Culture in Pharma
The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...
3 years agoBuilding a FAIR Culture in Pharma
The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...
3 years ago
Emerging Therapeutics in Translational Medicine: Nanotechnology
Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...
3 years agoEmerging Therapeutics in Translational Medicine: Nanotechnology
Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...
3 years ago
An Evaluation of -Omics Technology
Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...
4 years agoAn Evaluation of -Omics Technology
Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...
4 years ago
The Impact of Modern Technology on Clinical Operations
The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...
4 years agoThe Impact of Modern Technology on Clinical Operations
The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...
4 years ago
Blockchain, Data mining, and Disruptive Technologies: Digital Innovations in Clinical Research
In the last decade, innovations in data technology have greatly contributed to the quality and transparency of clinical research. System security, clinical trial design, and data analysis are some of the areas which have seen significant modernisation to keep up...
4 years agoBlockchain, Data mining, and Disruptive Technologies: Digital Innovations in Clinical Research
In the last decade, innovations in data technology have greatly contributed to the quality and transparency of clinical research. System security, clinical trial design, and data analysis are some of the areas which have seen significant modernisation to keep up...
4 years ago
Implementation of Machine Learning in Drug Development
Significant recent investment in computational technology has seen a number of new innovations arise in drug discovery - perhaps most notable machine learning (ML). By 2022, it is expected that AI technology will contribute $2.199 billion to pharma’s revenue, with...
4 years agoImplementation of Machine Learning in Drug Development
Significant recent investment in computational technology has seen a number of new innovations arise in drug discovery - perhaps most notable machine learning (ML). By 2022, it is expected that AI technology will contribute $2.199 billion to pharma’s revenue, with...
4 years ago
Real World Data and Evidence: Emerging Trends Across Clinical Research
Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...
4 years agoReal World Data and Evidence: Emerging Trends Across Clinical Research
Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...
4 years ago
An Evaluation of Data Capture and Visualization in Clinical Research
Data capture and visualization are the key components of clinical trial data analysis. However, with the explosion of COVID-19 around the world, data collection became difficult with poor patient recruitment and a reduction in face-to-face clinics. Advancements in telehealth have...
4 years agoAn Evaluation of Data Capture and Visualization in Clinical Research
Data capture and visualization are the key components of clinical trial data analysis. However, with the explosion of COVID-19 around the world, data collection became difficult with poor patient recruitment and a reduction in face-to-face clinics. Advancements in telehealth have...
4 years ago
Uses for AI in Pharma R&D
AI is by far the biggest buzzword in pharma today - but unlike many other high-profile trends, AI has the potential to rapidly and totally transform the sector forever, speeding up processes, automating basic tasks and making sense of the...
4 years agoUses for AI in Pharma R&D
AI is by far the biggest buzzword in pharma today - but unlike many other high-profile trends, AI has the potential to rapidly and totally transform the sector forever, speeding up processes, automating basic tasks and making sense of the...
4 years ago
R&D: The Impact of AI in 2020
Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...
5 years agoR&D: The Impact of AI in 2020
Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...
5 years ago